Illumina
ILMN
$0.67 (0.63%)
1D
1W
3M
1Y
5Y
ALL
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
PRNewsWire • 8 days ago • ILMN
Anna Richo joins Illumina's Board of DirectorsPRNewsWire • 13 days ago • ILMN
Illumina To Webcast Upcoming Investor ConferenceBusiness Wire • 15 days ago • ILMN
GRAIL to Host Capital Markets DayPRNewsWire • 21 days ago • ILMN
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAILZacks Investment Research • 25 days ago • ILMN
Illumina (ILMN) Q1 Earnings Beat, Adjusted Operating Loss WidensCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.